ICML 2025: Novel Agents in CLL

Could SGLT2 inhibitors help lower the risk of sudden cardiac death?

ICML 2025: Regimens for Patients With High-Risk CLL

ICML 2025: Fixed-Duration and MRD-Guided Regimens in CLL

CGRP Migraine Therapies in 2025: Navigating New Safety Warnings for Raynaud’s Phenomenon and Hypertension

Should children under 4 still get the MMRV vaccine? The American Academy of Pediatrics says yes

Breaking the Migraine Cycle: Understanding Medication Overuse Headache

Future Directions in Small Cell Lung Cancer Treatment

Small Cell Lung Cancer: Second-line Options Following Maintenance

Perspectives on Maintenance Therapy in Small Cell Lung Cancer

Should clopidogrel replace aspirin as the standard for CAD prevention?

Treat to Target: What it Is and How to Implement

Earlier Use of Biologics for Treating Lupus

Is FDA-backed elastography poised to replace biopsy as the driver of MASH drug development?

2025 Guideline Summary for the Clinical Treatment and Management of Systemic Lupus Erythematosus

Emerging Therapies in SLE: Recent Studies and Potential Game-Changing Treatments

Non-Invasive Biomarkers in SLE: A Promise of Better Diagnosis, Management, and Personalized Treatment?

New Guidelines for the Screening, Treatment, and Management of Lupus Nephritis

What does FDA’s approval of generic liraglutide mean for obesity care?

How will the first approval for MASH with fibrosis alter treatment pathways?